HomeBUSINESS
BUSINESS

New IITs for Oncolytic Virus to Begin for Head and Neck Cancer, Sarcoma: Oncolys
(Feb.13.2018)

Oncolys BioPharma President Yasuo Urata
Japanese biotech Oncolys BioPharma said on February 9 that new investigator initiated trials (IITs) are being planned for its oncolytic virus telomelysin (OBP-301) in Japan for the treatment of head and neck squamous cell carcinoma (HNSCC) and sarcoma ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar